Publications by authors named "William Ince"

Claim this Profile
C
Current landscape, successes, and key challenges in cancer vaccine clinical trials across the UK.
Robert A Watson, Darcy Ward, Pippa Corrie, Elisa Fontana, William Ince

Lancet Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study.
Kevin J Harrington, Ari J Rosenberg, Muh-Hwa Yang, Jessica L Geiger, Marc Oliva, William Ince

Oral Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Case of the Month' from Addenbrooke's Hospital, Cambridge, UK: surgery after near complete response to combined immunotherapy and tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma with inferior vena cava tumour thrombus.
James P Blackmur, James N Armitage, James O Jones, Antony C P Riddick, Thomas J Mitchell, William H J Ince

BJU Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor use in head and neck squamous cell carcinoma: the current landscape and future perspectives.
Elinor R Gatfield, John Tadross, William Ince

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility.
Brady T Hickerson, Svetlana N Petrovskaya, Harold Dickensheets, Raymond P Donnelly, William L Ince

J Virol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleiotropic Effects of Influenza H1, H3, and B Baloxavir-Resistant Substitutions on Replication, Sensitivity to Baloxavir, and Interferon Expression.
Brady T Hickerson, Simone E Adams, Subrata Barman, Lance Miller, Vladimir Y Lugovtsev, William L Ince

Antimicrob Agents Chemother· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of ongoing clinical trials in optic pathway gliomas.
Ciaran Scott Hill, Sara Castro Devesa, William Ince, Anouk Borg, Kristian Aquilina

Childs Nerv Syst· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-Emergent Influenza Virus Polymerase Acidic Substitutions Independent of Those at I38 Associated With Reduced Baloxavir Susceptibility and Virus Rebound in Trials of Baloxavir Marboxil.
William L Ince, Fraser B Smith, Julian J O'Rear, Michael Thomson

J Infect Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies.
Natalia A Ilyushina, Takashi E Komatsu, William L Ince, Eric F Donaldson, Nicolette Lee

Virol J· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.
John H Beigel, Hannah H Nam, Peter L Adams, Amy Krafft, William L Ince

Antiviral Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs.
Ivan Kosik, William L Ince, Lauren E Gentles, Andrew J Oler, Martina Kosikova

PLoS Pathog· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs.
Ivan Kosik, William L Ince, Lauren E Gentles, Andrew J Oler, Martina Kosikova

PLoS Pathog· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Simple Flow-Cytometric Method Measuring B Cell Surface Immunoglobulin Avidity Enables Characterization of Affinity Maturation to Influenza A Virus.
Gregory M Frank, Davide Angeletti, William L Ince, James S Gibbs, Surender Khurana

mBio· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility.
Christopher B Brooke, William L Ince, Jiajie Wei, Jack R Bennink, Jonathan W Yewdell

Proc Natl Acad Sci U S A· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.
Javier G Magadán, Meghan O Altman, William L Ince, Heather D Hickman, James Stevens

PLoS Pathog· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Greasing the SCIDs for universal flu antibodies.
Jonathan W Yewdell, William L Ince

Cell Host Microbe· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reassortment complements spontaneous mutation in influenza A virus NP and M1 genes to accelerate adaptation to a new host.
William L Ince, Aissatou Gueye-Mbaye, Jack R Bennink, Jonathan W Yewdell

J Virol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Most influenza a virions fail to express at least one essential viral protein.
Christopher B Brooke, William L Ince, Jens Wrammert, Rafi Ahmed, Patrick C Wilson

J Virol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection.
Suman R Das, Scott E Hensley, William L Ince, Christopher B Brooke, Anju Subba

Cell Host Microbe· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virology. Frameshifting to PA-X influenza.
Jonathan W Yewdell, William L Ince

Science· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy.
Suman R Das, Scott E Hensley, Alexandre David, Loren Schmidt, James S Gibbs, William L Ince

Proc Natl Acad Sci U S A· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells.
Jeffrey A Anderson, Nancie M Archin, William Ince, Daniel Parker, Ann Wiegand

J Virol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model.
William L Ince, Liguo Zhang, Qi Jiang, Kathryn Arrildt, Lishan Su

J Virol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouse.
Shailesh K Choudhary, Naser L Rezk, William L Ince, Manzoor Cheema, Liguo Zhang

J Virol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization.
William L Ince, Patrick R Harrington, Gretja L Schnell, Milloni Patel-Chhabra, Christina L Burch

J Virol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis